BioHarvest Sciences Inc. - Common Stock (BHST)
7.3299
+0.3499 (5.01%)
NASDAQ · Last Trade: Jun 10th, 11:50 AM EDT

BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.
Via Benzinga · March 4, 2025

Tate & Lyle and BioHarvest Sciences partner to develop sustainable and affordable plant-based molecules for food and beverage industry.
Via Benzinga · December 11, 2024